Methotrexate polyglutamates in the treatment of acute lymphblastic leukemia and the drug resistance mechanics
WANG Yu-Cheng, GU Long-Jun
Abstract No abstvact available
Cite this article:
WANG Yu-Cheng,GU Long-Jun. Methotrexate polyglutamates in the treatment of acute lymphblastic leukemia and the drug resistance mechanics[J]. 中国当代儿科杂志, 2000, 2(5): 361-363.
WANG Yu-Cheng,GU Long-Jun. Methotrexate polyglutamates in the treatment of acute lymphblastic leukemia and the drug resistance mechanics[J]. CJCP, 2000, 2(5): 361-363.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2000/V2/I5/361
[1]
WU Yuan-Yuan, CAI Sheng-Yang, HUANG Wei, LI Si-Si, LI Wei, DONG Ao. Clinical and laboratory characteristics of juvenile myelomonocytic leukemia
[2]
CHENG Yan-Qin, ZHAI Xiao-Wen. Clinical application of minimal residual disease detection in childhood acute leukemia
[3]
ZHANG Wan-Yan, ZHANG Yuan, DONG Nan-Nan, WANG Ying-Chao, SHENG Guang-Yao, XU Xue-Ju, LIU Yu-Feng. Clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis in children: a clinical analysis of 24 cases
[4]
CHEN Xiao-Xiao, SHEN Shu-Hong. Research advances in pharmacogenomics of mercaptopurine
[5]
LU Yun-Yun, LUO Rong, FU Zhou. Pathogen distribution and bacterial resistance in children with severe community-acquired pneumonia
[6]
XU Jin-Yun, LUO Jian-Ming. Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia
[7]
FU Xiao-Yan, XIE Xiao-Tian, ZHAO Yan. Neurocognitive function of children with acute lymphoblastic leukemia and long-term disease-free survival and related influencing factors
[8]
WANG Ni-Na, YE Qi-Dong. Advances in targeted therapy for childhood acute myeloid leukemia
[9]
SUN Qing, XIE Yao, ZHAO Wei-Hong, HUA Ying, WU Peng-Hui, LI Shuo, LU Xin-Tian. Adverse effects of high-dose methotrexate therapy
[10]
WU Jun, LU Ai-Dong, ZHANG Le-Ping. Clinical characteristics and prognostic analysis of children and adolescents over 10 years of age with acute lymphoblastic leukemia
[11]
KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie. Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia
[12]
CHEN Zai-Sheng, ZHENG Ling, CHEN Yi-Qiao, YANG Jing-Hui, LI Jian. Pathogens of infections in the induction period of childhood acute lymphoblastic leukemia and drug resistance of isolated strains
[13]
ZHANG Pei-Fen, FENG Xiao-Qin, WU Cui-Ling, ZHANG Yu-Ming. Clinical features of children with acute lymphoblastic leukemia complicated by pulmonary infection after chemotherapy
[14]
NI Ya-Ru, XU Xiao-Jun, TANG Yong-Min. Progress in clinical studies of chimeric antigen receptor engineered T cells for treatment of childhood cancer
[15]
ZHANG Hui-Fen, BAI Hai-Tao, LI Ji-Ming, XIE Hui, WANG Ye. Association of drug resistance of Mycoplasma pneumoniae with DNA load and genotypes in children with Mycoplasma pneumoniae pneumonia
